HuGE Literature Finder
Records
1
-
30
| Programmed death-ligand 1 expression and its associations with clinicopathological features, prognosis, and driver oncogene alterations in surgically resected lung adenocarcinoma. Lung cancer (Amsterdam, Netherlands) 2021 Sep 161 163-170. Takamochi Kazuya, Hara Kieko, Hayashi Takuo, Kohsaka Shinji, Takahashi Fumiyuki, Suehara Yoshiyuki, Suzuki Ken |
| Frequency of actionable molecular drivers in lung cancer patients with precocious brain metastases. Clinical neurology and neurosurgery 2021 Jul 208 106841. Hanke Benjamin, Jünger Stephanie T, Kirches Elmar, Waldt Natalie, Schreiber Jens, Lücke Eva, Franke Sabine, Sandalcioglu I Erol, Warnke Jan-Peter, Meisel Hans-Jörg, Prell Julian, Scheller Christian, Braunsdorf Werner E K, Preusser Matthias, Schildhaus Hans-Ulrich, Mawrin Christi |
| Retrospective analysis of eleven gene mutations, PD-L1 expression and clinicopathological characteristics in non-small cell lung cancer patients. Asian journal of surgery 2021 Jul . Liu Yanqing, Wu Aihua, Li Xinjian, Wang Shanshan, Fang Shuyu, Mo Yij |
| Modeling clinical responses to targeted therapies by patient-derived organoids of advanced lung adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 Jun . Kim Seok-Young, Kim Sang-Min, Lim Sumin, Lee Ji Yeon, Choi Su-Jin, Yang San-Duk, Yun Mi Ran, Kim Chang Gon, Gu Seo Rin, Park Chae-Won, Park A-Young, Lim Sun Min, Heo Seong Gu, Kim Hyunki, Cho Byoung Ch |
| The genomic landscape of young and old lung cancer patients highlights age-dependent mutation frequencies and clinical actionability in young patients. International journal of cancer 2021 Apr . Cai Lei, Chen Yong, Tong Xiaoling, Wu Xue, Bao Hua, Shao Yang, Luo Zhuang, Wang Xuming, Cao Ya |
| Exploring the resistance mechanisms of second-line osimertinib and their prognostic implications using next-generation sequencing in patients with non-small-cell lung cancer. European journal of cancer (Oxford, England : 1990) 2021 Mar 148 202-210. Lee Kyoungmin, Kim Deokhoon, Yoon Shinkyo, Lee Dae Ho, Kim Sang- |
| Morphological and genetic heterogeneity of synchronous multifocal lung adenocarcinoma in a Chinese cohort. BMC cancer 2021 Feb 21 (1): 176. Zhu Donglin, Cao Dan, Shen Minghong, Lv Jinghu |
| The landscape of kinase domain duplication in Chinese lung cancer patients. Annals of translational medicine 2020 Dec 8 (24): 1642. Wu Di, Xie Yuancai, Jin Chang'e, Qiu Jinfan, Hou Ting, Du Haiwei, Chen Songan, Xiang Jianxing, Shi Xi, Liu Junli |
| Genetic profile of non-small cell lung cancer (NSCLC): A hospital-based survey in Jinhua. Molecular genetics & genomic medicine 2020 Jul e1398. Chen Xianguo, Xu Bo, Li Qiang, Xu Xiaoyi, Li Xianshuai, You Xia, Yu Zhaon |
| Status of 10 targeted genes of non-small cell lung cancer in eastern China: A study of 884 patients based on NGS in a single institution. Thoracic cancer 2020 Jul . Li Dan, Ding Li, Ran Wenwen, Huang Yan, Li Guangqi, Wang Chengqin, Xiao Yujing, Wang Xiaonan, Lin Dongliang, Xing Xiaomi |
| Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non-small cell lung cancer: Analysis of over 8000 cases. Cancer 2020 May . Mack Philip C, Banks Kimberly C, Espenschied Carin R, Burich Rebekah A, Zill Oliver A, Lee Christine E, Riess Jonathan W, Mortimer Stefanie A, Talasaz AmirAli, Lanman Richard B, Gandara David |
| Expression Profiling of Driver Genes in Female Never-smokers With Non-adenocarcinoma Non-small-cell Lung Cancer in China. Clinical lung cancer 2020 Feb . Zhao Yiming, Dong Yu, Zhao Ruiying, Zhang Bo, Wang Shuyuan, Zhang Lele, Hu Minjuan, He Qingnan, Zhang Wei, Han Baoh |
| Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2020 Jan . Guisier Florian, Dubos-Arvis Catherine, Viñas Florent, Doubre Helene, Ricordel Charles, Ropert Stanislas, Janicot Henri, Bernardi Marie, Fournel Pierre, Lamy Régine, Pérol Maurice, Dauba Jerome, Gonzales Gilles, Falchero Lionel, Decroisette Chantal, Assouline Pascal, Chouaid Christos, Bylicki Olivi |
| The clinical impact of family history of cancer in female never-smoker lung adenocarcinoma. Lung cancer (Amsterdam, Netherlands) 2019 Jul 136 15-22. Lee Youngjoo, Jeon Jae Hyun, Goh Sung-Ho, Roh Hanseong, Yun Ji-Young, Kwon Nak-Jung, Choi Jin Ho, Yang Hee Chul, Kim Moon Soo, Lee Jong Mog, Lee Geon Kook, Han Ji-Yo |
| Performance of Oncomine Fusion Transcript kit for formalin-fixed, paraffin-embedded lung cancer specimens. Cancer science 2019 Apr . Sakai Kazuko, Ohira Tatsuo, Matsubayashi Jun, Yoneshige Azusa, Ito Akihiko, Mitsudomi Tetsuya, Nagao Toshitaka, Iwamatsu Emi, Katayama Jin, Ikeda Norihiko, Nishio Kazu |
| [Association between the HER2 Gene Status and the Efficacy of First-line Pemetrexed Combined with Platinum Chemotherapy in Patients with Advanced Lung ?Adenocarcinoma]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2019 Mar 22 (3): 137-142. Li Panhua, Li Banban, Shi Yunshu, Zhang Fengming, Shen Shujing, Li Xing |
| Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer. The oncologist 2019 Mar . Wen Shiwang, Dai Lei, Wang Lei, Wang Wenjian, Wu Duoguang, Wang Kefeng, He Zhanghai, Wang Aodi, Chen Hui, Zhang Peng, Dong Xiaowei, Dong Yu-An, Wang Kai, Yao Ming, Wang Mingh |
| Analysis of the frequency of oncogenic driver mutations and correlation with clinicopathological characteristics in patients with lung adenocarcinoma from Northeastern Switzerland. Diagnostic pathology 2019 Feb 14 (1): 18. Grosse Alexandra, Grosse Claudia, Rechsteiner Markus, Soltermann Al |
| Lung cancer family history and exposure to occupational/domestic coal combustion contribute to variations in clinicopathologic features and gene fusion patterns in non-small cell lung cancer. Thoracic cancer 2019 (4): 695-707. Chen Ying, Li Guangjian, Lei Yujie, Yang Kaiyun, Niu Huatao, Zhao Jie, He Rui, Ning Huanqi, Huang Qiubo, Zhou Qinghua, Huang Yunch |
| Oncogenic driver mutations in Swiss never smoker patients with lung adenocarcinoma and correlation with clinicopathologic characteristics and outcome. PloS one 2019 14 (8): e0220691. Grosse Claudia, Soltermann Alex, Rechsteiner Markus, Grosse Alexand |
| Frequency and clinical significance of NF1 mutation in lung adenocarcinomas from East Asian patients. International journal of cancer 2018 Sep . Pan Yunjian, Yuan Chongze, Cheng Chao, Zhang Yiliang, Ma Yuan, Zheng Difan, Zheng Shanbo, Li Yuan, Jin Yan, Sun Yihua, Chen Haiqu |
| Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion. Genes, chromosomes & cancer 2018 Aug . Wu Shang-Gin, Liu Yi-Nan, Yu Chong-Jen, Yang James Chih-Hsin, Shih Jin-Yu |
| Targeted next generation sequencing identified a high frequency genetic mutated profile in wood smoke exposure-related lung adenocarcinoma patients. Oncotarget 2018 Jul 9 (55): 30499-30512. Soca-Chafre Giovanny, Hernández-Pedro Norma, Aviles-Salas Alejandro, Versón Carmen Alaez, Sánchez Karol Carrillo, Cardona Andrés F, Avila-Moreno Federico, Barrios-Bernal Pedro, Flores-Estrada Diana, Arrieta Osc |
| Aberrant status and clinicopathologic characteristic associations of 11 target genes in 1,321 Chinese patients with lung adenocarcinoma. Journal of thoracic disease 2018 Jan 10 (1): 398-407. Zhao Mengnan, Zhan Cheng, Li Ming, Yang Xiaodong, Yang Xinyu, Zhang Yong, Lin Miao, Xia Yifeng, Feng Mingxiang, Wang Q |
| HPV Status and Mutation Analysis Using Multiparallel Sequencing in Distal Oesophageal and Gastro-oesophageal Junction Adenocarcinomas. Folia biologica 2018 64 (2): 41-45. Vošmik M, Vošmiková H, Sieglová K, Sirák I, Laco J, Ryška A, Petera J, Melichar B, Soumarová |
| The utilization of next-generation sequencing to detect somatic mutations and predict clinical prognosis of Chinese non-small cell lung cancer patients. OncoTargets and therapy 2018 11 2637-2646. Cao Liming, Long Long, Li Min, Yang Huaping, Deng Pengbo, Mao Xinru, Xiang Jianxing, Li Bing, Zhang Tengfei, Hu Chengpi |
| Next-Generation Sequencing Approach to Non-Small Cell Lung Carcinoma Yields More Actionable Alterations. Archives of pathology & laboratory medicine 2017 Dec . Mehrad Mitra, Roy Somak, Bittar Humberto Trejo, Dacic San |
| The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations-The Lung Cancer Mutation Consortium (LCMC2). Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Dec . Aisner Dara L, Sholl Lynette M, Berry Lynne, Rossi Michael, Chen Heidi, Fujimoto Junya, Moreira Andre L, Ramalingam Suresh, Villaruz Liza C, Otterson Gregory A, Haura Eric B, Politi Katerina, Glisson Bonnie S, Cetnar Jeremy, Garon Edward, Schiller Joan, Waqar Saiama, Sequist Lecia V, Brahmer Julie R, Shyr Yu, Kugler Kelly, Wistuba Ignacio Ivan, Johnson Bruce E, Minna John D, Kris Mark G, Bunn Paul A, Kwiatkowski David |
| Comprehensive investigation of clinicopathologic features, oncogenic driver mutations and immunohistochemical markers in peripheral lung squamous cell carcinoma. Journal of thoracic disease 2017 Nov 9 (11): 4434-4440. Zhang Yang, Zheng Difan, Li Yuan, Pan Yunjian, Sun Yihua, Chen Haiqu |
| Beyond KRAS: Practical Molecular Targets in Pancreatic Adenocarcinoma. Case reports in oncology 0 12 (1): 7-13. Grinshpun Albert, Zarbiv Yonaton, Roszik Jason, Subbiah Vivek, Hubert Aya |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jan 20, 2022
- Content source: